MedPlus Health Services posted Q1 FY27 revenue of ₹1,879.6 Cr, a robust 21.8% year-on-year increase.

However, gross margins dipped to 24.5%, and Consolidated Operating EBITDA came in at ₹65.1 Cr, down 10.6% YoY.

Net profit stood at ₹33.17 Cr, marking a 21.7% YoY decline.

The company continues its cluster-based expansion strategy, adding 146 net new stores this quarter to reach 5,476 total outlets.

Notably, 27% of its store network is less than two years old, indicating future growth potential.

MedPlus aims to leverage its omni-channel leadership for market expansion and faster deliveries, while increasing its private label contribution for enhanced margins across pharma and FMCG.

Key financial metrics show strong operational cash flow of ₹125.2 Cr, and a healthy closing cash balance of ₹621.9 Cr.

The forward-looking plan emphasizes deepening market penetration and expanding its omni-channel reach for sustainable performance.